Publications
BIBLIOGRAPHY
Peer-Reviewed Publications
1. Goodrum, K.J., L.L. McCormick, and B.J. Schneider. Group B streptococcus-induced nitric oxide production in murine macrophages is CR3 (CD11b/CD18) Dependent. Infection and Immunity 1994; 62:3102-3107.
2. Schneider BJ, Avram AM, Shulkin BL, Kalemkerian GP. False-positive findings with positron emission tomography in non-small cell lung cancer. Clinical Advances in Hematology & Oncology 2005; 3(7):571-573.
3. Schneider BJ, Ben-Josef E, McGinn C, Chang A, Colletti L, Normolle D, Lawrence T, Zalupski M. Capecitabine and radiation therapy preceded and followed by combination chemotherapy in advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2005; 63(5):1325-1330.
4. Avram AM, Mackie GC, Schneider BJ, Kalemkerian GP, Shulkin BL. Differentiation between carcinoid and sarcoid with FDG-PET and 111-In-Octreotide. Clinical Nuclear Medicine 2006; 31(4):197-200.
5. Schneider BJ and Urba SG. Pre-operative chemoradiation for the treatment of locoregional esophageal cancer: the standard of care? Semin Radiat Oncol 2007; 17:45-52.
6. Schneider BJ, El-Rayes B, Muler JH, Philip PA, Kalemkerian GP, Griffith KA, Zalupski MM. Phase II trial of carboplatin, gemcitabine and capecitabine in patients with carcinoma of unknown primary site. Cancer 2007; 110:770-775.
7. Schneider, BJ. Management of recurrent small cell lung cancer. JNCCN 2008; 6:323-331.
8. Schneider BJ, Kalemkerian GP. Lung cancer: Treatment of non-small cell lung cancer in the elderly. CancerNews.com: http://www.cancernews.com/data/Article/273.asp, 2005.
9. Schneider BJ. Non-small cell lung cancer staging: proposed revisions to the TNM system. Cancer Imaging 2008; 8(1): 181-185.
